C07C 311 - Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups

Patents for C07C 311 - Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups (17,647)
12/2011
12/06/2011	CA2615019C Hiv reverse transcriptase inhibitors
12/06/2011	CA2380858C Inhibitors of aspartyl protease
12/01/2011	WO2011149213A2 Novel derivative having inhibitory activity against 11β-hsd1, preparation method thereof, and pharmaceutical composition containing same as active ingredient
12/01/2011	WO2011148971A1 Process for preparation of fluorine-containing sulfonyl imide compounds
12/01/2011	WO2011148961A1 Method for producing fluorine-containing imide compound
12/01/2011	WO2011148958A1 Process for preparation of fluorine-containing imide compounds
12/01/2011	WO2011113925A3 Carbonylation of organic zinc compounds
12/01/2011	US20110294853 Bis Aromatic Compounds for Use in the Treatment of Inflammation
12/01/2011	US20110294793 Hydroxyphenyl sulfonamides as antiapoptotic bcl inhibitors
12/01/2011	US20110294775 Novel compounds
11/2011
11/29/2011	US8067437 Beta-2-adrenoreceptor agonists
11/24/2011	WO2011145669A1 Amide derivative
11/24/2011	WO2011144992A1 Polymer electrolyte, manufacturing method for polymer electrolyte, imide monomer, and battery
11/24/2011	WO2011144054A1 Dibenzocyclooctene lignan derivatives and uses thereof in treatment of viral hepatitis
11/24/2011	US20110286922 Imaging and radiotherapy methods
11/24/2011	US20110283466 Optical brighteners and compositions comprising the same
11/23/2011	EP2388258A1 Novel vanilloid receptor ligands and their use for producing medicaments
11/23/2011	EP2387559A1 Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
11/23/2011	CN102249958A Inhibitor of benzoylammonia histone deacetylase
11/22/2011	US8063242 2-aryl-propionic acids and pharmaceutical compositions containing them
11/22/2011	US8063103 Polymorphs of acyl sulfonamides
11/22/2011	US8063036 Benzamides and related inhibitors of factor Xa
11/17/2011	US20110281898 Phenoxiacetic acid derivatives
11/17/2011	CA2799399A1 Low chlorine odor control compositions
11/16/2011	CN102241615A Multifunctional chiral amine compound, preparation method and application thereof
11/16/2011	CN102241614A Synthesis method of N-alkyl-substituted amide compounds
11/16/2011	CN101429142B Nitrogen-containing polyhydroxy fragrant compounds, preparation and uses thereof
11/16/2011	CN101245040B Process for producing 4-ethynyl benzene sulfonamide (I)
11/10/2011	US20110275635 Small molecule inhibitors of nads, namnat, and nmnat
11/10/2011	US20110275619 Inhibitors of bace1 and methods for treating alzheimer's disease
11/10/2011	US20110275612 Alpha-substituted n-sulfonyl gylcine amides antagonists of ccr10, compositions containing the same and methods for using them
11/09/2011	EP2384318A2 Compounds and methods for inhibiting nhe-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders
11/09/2011	EP1658263B9 Novel aminobenzophenone compounds
11/09/2011	CN102234211A Method for preparing diaryl methane with acidic hydrogen
11/09/2011	CN101343251B Thrombopoietin mimetics
11/08/2011	CA2614757C Process for the preparation of sulfonamide derivatives
11/08/2011	CA2343414C Fc receptor modulators and uses thereof
11/03/2011	US20110269970 Phenethanolamine Derivatives for Treatment of Respiratory Diseases
11/03/2011	US20110269689 High penetration compositions and their applications
11/02/2011	EP2382227A1 Sulfurizing reagents and their use for oligonucleotides synthesis
11/02/2011	EP2382189A1 Toluidine sulfonamides and their use
11/02/2011	CN102229547A Naphthyl phenyl ether benzenesulfonamide derivative and preparation method and purpose thereof
11/01/2011	USRE42889 α- and β- amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
11/01/2011	US8049026 Hydrophobic, conductive and stable and have uses as solvents and in electrochemical devices; such as complex of cyclohexyl-15-crown-5 or alkyl amine with a lithium bis(trifluoromethane)sulfonimide
11/01/2011	US8048867 9-substituted minocycline compounds
11/01/2011	CA2458534C Phenethanolamine derivatives for treatment of respiratory diseases
11/01/2011	CA2409741C Tnf-.alpha. production inhibitors
10/2011
10/27/2011	US20110263556 New Compounds
10/26/2011	EP2380882A1 Salts of heterocyclic anions and their uses as ionic conductive materials
10/25/2011	US8044240 Polymorphic form of N-(S)-(3,4-difluoro-2-(2-fluoro-4-iodophenylamino)-6-methoxyphenyl)-1-(2,3-dihydroxypropyl)cyclopropane-1-sulfonamide and uses thereof
10/25/2011	US8044090 N-(2-arylethyl)benzylamines as antagonists of the 5-HT6 receptor
10/20/2011	WO2011043519A3 Sulfonamide derivatives as serotonin receptor antagonist and serotonin reuptake inhibitor
10/20/2011	US20110257183 Bis-aryl sulfonamides
10/19/2011	EP2376431A1 Novel substituted aryl derivatives, their process of preparation and their therapeutical uses as anti-hiv agents
10/19/2011	CN102219718A New synthesis method for p-tolunesulfonyl carbamide
10/19/2011	CN102219717A N-phenyl aryl formamide derivative, preparation method thereof and use thereof
10/18/2011	US8039495 Biphenyl carboxylic acids and bioisosteres as glycogen synthase activators
10/18/2011	US8039493 Biaryl sulfonamide derivatives
10/18/2011	CA2551167C Aminoalcohol derivatives
10/13/2011	US20110251206 Squaramide derivatives as CXCR2 antagonist
10/12/2011	EP2374792A1 N-substituted benzene sulfonamides
10/12/2011	EP1385820B1 Anthranilic acid amides, method for the production thereof, their use as antiarrhythmia agents, and pharmaceutical preparations thereof
10/12/2011	CN102216249A Naphthylacetic acids
10/12/2011	CN102212022A Diphenyl methanol derivatives and preparation method and application thereof
10/11/2011	US8034810 Matrix metalloproteinase inhibitors; antiinflammatory agengs; rheumatoid arthritis, osteoarthritis; antitumor, anticarcinogenic, and antimetastasis agents; respiratory system disorders, chronic obstructive pulmonary disease, deblocking, deprotecting
10/06/2011	WO2011120926A1 4-cyclopropyl-2-[(5-oxo-4,5-dihydro-1,2,4-triazol-1-yl)(thio)carbonylaminosulfonyl]benzoic acid derivatives, processes for preparing them and use as herbicides and plant growth regulators
10/05/2011	EP2371823A1 Cyclopropyl-substituted phenylsulfonylamino(thio)carbonyltriazolinones, their production and use as herbicides and plant growth regulators
10/05/2011	EP2371814A1 Aminoethylaromatic compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor
10/05/2011	CN102206177A 1-naphthyl benzophenone derivatives, and preparation method and application thereof
10/05/2011	CN102206176A Preparation method of tamsulosin racemate
10/05/2011	CN102206172A Substituted diaryl compound and preparation method and antiviral application thereof
10/04/2011	US8030517 CCR9 inhibitors and methods of use thereof
10/04/2011	US8030356 N-hydroxylsulfonamide derivatives as new physiologically useful nitroxyl donors
09/2011
09/29/2011	WO2011119560A1 Mixture of polyfluoroalkylsulfonamido alkyl amines
09/29/2011	WO2011119555A1 Surfactant composition from polyfluoroalkylsulfonamido alkyl amines
09/29/2011	WO2011119551A1 Polyfluoroalkylsulfonamido alkyl halide intermediate
09/29/2011	WO2011119345A2 Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
09/29/2011	US20110237834 Polyfluoroalkylsulfonamido alkyl halide intermediate
09/29/2011	US20110237793 Process for preparing antiviral compound
09/29/2011	US20110237553 Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
09/29/2011	CA2792276A1 Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
09/28/2011	CN102203058A Sulfur-linked compounds for treating opthalmic diseases and disorders
09/28/2011	CN102199113A Method for screening anti-cancer compounds inhibiting function of TM4SF5 and anti-cancer composition containing chalcone compounds
09/22/2011	WO2011025982A3 Tetracycline compounds
09/22/2011	US20110230446 Cathepsin cysteine protease inhibitors
09/22/2011	US20110230428 Certain kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof
09/21/2011	EP1699755B1 Process for preparing fluorochemical monoisocyanates
09/21/2011	EP1487428B1 Amino-substituted (e)-2,6-dialkoxystyryl 4-substituted benzylsulfones for treating proliferative disorders
09/21/2011	CN102197023A Compounds for treating ophthalmic diseases and disorders
09/21/2011	CN102197019A Thyroid receptor ligands
09/21/2011	CN101343250B Thrombopoietin mimetics
09/20/2011	US8022248 3-[2-(3-Cyanophenoxy)-4-(trifluoromethyl)phenyl]propanoic acid;prostaglandin D2 inhibitor, orphan receptor CRTH2 antagonist; antiinflammatory, analgesic, antipyretic; respiratory system disorders: asthma and rhinitis; coupling amino/thio-phenyl derivatives with ester followed by hydrolysis to acid
09/20/2011	CA2669311C Diaryl, dipyridinyl and aryl-pyridinyl derivatives and uses thereof
09/20/2011	CA2471943C .beta.-amyloid protein production-secretion inhibitors
09/15/2011	US20110223177 Treatment of fibrotic eye disorders
09/14/2011	CN102186845A S1p receptors modulators and their use thereof
09/14/2011	CN102180911A Nitrogen-oxygen ligand with planar chirality and central chirality and metal complex thereof
09/14/2011	CN102180873A Functional ionic liquid and preparation method thereof
09/14/2011	CN102180816A Preparation method of asymmetric type bi-fluoro sulfimide potassium
09/13/2011	US8017803 Process for the preparation of tamsulosin and intermediates thereof

1 ... 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 ... 177